Keywords: 7; IIV; intraindividual variability; CCPT-II; Conner's Continuous Performance Test-II; WASI-II; Wechsler Abbreviated Scale of Intelligence-Second Edition; WRAT-3; Wide-Range Achievement Test-3; Attention; Intraindividual variability; Intelligence; Academic a
مقالات ISI 7 (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: 7; CMI; cell-mediated immunity; GMT; geometric mean titer; HAI; hemagglutination inhibition; IFN-γ; interferon-γ; IIV; inactivated influenza vaccine; IR; interferon-γ release; NT; neutralizing antibody; one dose; 1st dose of a vaccine; two doses; 2nd dose
Keywords: 7; Hemagglutinin; Influenza; Potency; Immunogenicity; Single-radial immunodiffusion; Stress; Trypsinization; Vaccine; AUC; area-under-curve; Bv; B Victoria lineage; By; B Yamagata lineage; HA; hemagglutinin; HI; hemagglutination inhibition; IDMS; isotope dil
Keywords: 7; Sleep; Sleep complaint; Intraindividual variability; Night-to-night variability; Insomnia identity; CG; Complaining Good Sleepers; CP; Complaining Poor Sleepers; IIV; Intraindividual Variability; iSD; Intraindividual Standard Deviation; MANCOVA; Multivari
Keywords: 7; ACIP; Advisory Committee on Immunization Practices; CI; confidence interval; IIV; inactivated influenza vaccine; IIV3; trivalent IIV; IIV4; quadrivalent IIV; LAIV; live attenuated influenza vaccine; LAIV3; trivalent LAIV; LAIV4; quadrivalent LAIV; LINKS;
Keywords: 7; ACIP; Advisory Committee on Immunization Practices; CI; Confidence Interval; ED; Emergency Department; HEDIS; Health Plan Employer Data and Information Set; ICD9; International Classification of Disease, 9th Revision, Clinical Modification; IIV; inactivat
Keywords: 7; Actinia equina; animal personality; field; IIV; laboratory; repeatability;
Keywords: 7; ICD-9; International Classification of Diseases, Ninth Revision; IIV; Inactivated influenza vaccine; PD; Prevalence difference; PR; Prevalence ratio; VSD; Vaccine Safety Datalink;
Keywords: 7; pharmacokinetics; physiological model; inhibition; bioavailability; DCA; dichloroacetic acid; GSTZ1-1; glutathione transferase zeta 1; GI; gastrointestinal; IIV; inter-individual variability; pcVPC; prediction-corrected visual predictive check;
Keywords: 7; CMI; cell-mediated immunity; HAI; hemagglutination inhibition; IFN-γ; interferon-γ; IIV; inactivated influenza vaccine; IR; interferon-γ release; Influenza; Antigen; Interferon-gamma; Cell-mediated immunity; Vaccine; Humoral immunity;
Keywords: 7; Lithium; Drug compliance; TDM; Population pharmacokinetic analysis; Markov modelling; â2LL; 2xlog(likelihood); BD; bipolar disease; CrCL; creatinine clearance; EBE׳s; Empirical Bayes Estimates; IIV; inter-individual variability; IOV; inter-occasion var
Keywords: 7; CPP; chronic pelvic pain; IIV; internal iliac vein; OV; ovarian vein; PCS; pelvic congestion syndrome; PVI; pelvic vein incompetence;
Keywords: 7; Egg allergy; live attenuated influenza vaccine; asthma; recurrent wheezing; safety; BTS; British Thoracic Society; IIV; Inactivated influenza vaccine; IQR; Interquartile range; LAIV; Live attenuated influenza vaccine; SIGN; Scottish Intercollegiate Guidel
Keywords: 7; ACIP; Advisory Committee on Immunization Practices; ADEM; acute disseminated encephalomyelitis; AE; adverse events; AIDP; acute inflammatory demyelinating polyradiculoneuropathy; AMAN; acute motor axonal neuropathy; AMSAN; acute motor and sensory neuropat
Keywords: 7; AIC; Akaike information criteria; BCS; Biopharmaceutics Classification System; BLQ; below the limit of quantification; CI; confidence interval; CYP2D6; cytochrome P450 2D6; GC-MS; gas chromatography coupled to mass spectrometry; IIV; interindividual var
Keywords: 7; ALFF; amplitude of low-frequency fluctuation; DLPFC; dorsolateral prefrontal cortex; FES; first-episode schizophrenia; fMRI; functional magnetic resonance imaging; IIV; inter-individual variability; PFC; prefrontal cortices; vMPFC; ventromedial prefrontal
Keywords: 7; Food allergy; medication allergy; vaccine allergy; IIV; Inactivated influenza vaccine; ILE; Intravenous lipid emulsion; LAIV; Live attenuated influenza vaccine; TPN; Total parenteral nutrition;
Keywords: 7; AUCÏ; Area under the curve within the dosing interval; BS; Bootstrap; CL; Clearance; CLCR; Creatinine clearance; CP; Cerebral palsy; GAGE; Gestational age; GERD; Gastroesophageal reflux disease; IIV; Inter-individual variability; MTT; Mean transit time;
Keywords: 7; boldness; hermit crab; IIV; Pagurus bernhardus; personality; plasticity; startle response;
Intra-individual variability and psychotic-like experiences in adolescents: Findings from the ALSPAC cohort
Keywords: 7; ADHD; attention deficit hyperactivity disorder;; ALSPAC; Avon Longitudinal Study of Parents and Children; CDR; Cognitive Drug Research; ICV; individual coefficient of variation; IIV; intra-individual variability; ISD; individual standard deviation; PLE; p
Report on eighth WHO meeting on development of influenza vaccines that induce broadly protective and long-lasting immune responses: Chicago, USA, 23-24 August 2016
Keywords: 7; Influenza; Pandemic influenza vaccine; Seasonal influenza vaccine; Universal influenza vaccine; Vaccine development; Nextgeneration influenza vaccine; ADCC; Antibody-dependent cell-mediated cytotoxicity; AE; Adverse event; CMI; cell-mediated immunity; CON
Prediction of human pharmacokinetics of activated recombinant factor VII and B-domain truncated factor VIII from animal population pharmacokinetic models of haemophilia
Keywords: 7; rFVIIa; activated recombinant factor VII; rFVIII; recombinant factor VIII; PK; pharmacokinetic; pcVPC; prediction corrected visual predictive check; IIV; inter-individual variability; RSE; relative standard error; GOF; goodness-of-fit; Allometric scaling;
Defining level A IVIVC dissolution specifications based on individual in vitro dissolution profiles of a controlled release formulation
Keywords: 7; AUC; area under the curve; BE; bioequivalence; CI; confidence interval; CL; clearance; Cmax; maximum plasma concentration; CR; controlled release; CV; coefficient of variation; f2; similarity factor; FTFF; the fastest tablet of the fastest dissolving form
Novel hemagglutinin nanoparticle influenza vaccine with Matrix-M⢠adjuvant induces hemagglutination inhibition, neutralizing, and protective responses in ferrets against homologous and drifted A(H3N2) subtypes
Keywords: 7; NIV; nanoparticle influenza vaccine; HANP; hemagglutinin nanoparticle; IIV; inactivated influenza vaccine; IIV-HD; inactivated influenza vaccine high dose; VE; vaccine efficacy; Ctrl; control; Recombinant; Hemagglutinin; Nanoparticles; Influenza; Vaccine;
BezpieczeÅstwo szczepieÅ profilaktycznych u chorych na choroby alergiczne
Keywords: 7; szczepienia profilaktyczne; alergia na biaÅko jaja kurzego; anafilaksja; Preventive vaccinations; Egg allergy; Anaphylaxis; AAAAI; American Academy of Allergy, Asthma and Immunology; ACAAI; American College of Allergy, Asthma and Immunology; ACIP; Adviso
Association of vaccine handling conditions with effectiveness of live attenuated influenza vaccine against H1N1pdm09 viruses in the United States
Keywords: 7; CDC; US Centers for Disease Control and Prevention; E47; glutamic residue at position 47; IIV; inactivated influenza vaccine; LAIV; live attenuated influenza vaccine; SPSN; Sentinel Provider Surveillance Network; TNCC; test-negative case control; US; Unit
Pharmacokinetics, exposure-cognition, and exposure-efficacy relationships of perampanel in adolescents with inadequately controlled partial-onset seizures
Keywords: 7; AED; antiepileptic drug; AMPA; α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate; Cav,ss; average steady-state plasma concentration at; CDR; Cognitive Drug Research system; CNS; central nervous system; CL/F; apparent clearance; CYP; cytochrome P450; IIV
Safety and pharmacokinetic profile of rufinamide in pediatric patients aged less than 4 years with Lennox-Gastaut syndrome: An interim analysis from a multicenter, randomized, active-controlled, open-label study
Keywords: 7; Lennox-Gastaut syndrome; Rufinamide; Antiepileptic drug therapy; Randomized study; Pharmacokinetic; safety; Infants; AED; antiepileptic drug; AUC; area under the concentration-time curve; Cav; steady-state exposure; CI; confidence interval; CL/F; appare
Characterizing and Forecasting Individual Weight Changes in Term Neonates
Keywords: 7; weight loss; newborns; baby; child; population approach; IIV; Interindividual variability; Kin; Time-dependent rate of weight gain; KinBase; Basal rate of weight gain; KinPNA; Shape of the time-dependent weight gain curve; Kout; Time-dependent rate consta
Influenza vaccination type, live, attenuated influenza vaccine (LAIV) versus inactivated influenza vaccine (IIV), received by children, United States, 2011â12 through 2013â14 influenza seasons
Keywords: 7; ACIP; Advisory Committee on Immunization Practices; IIV; Inactivated Influenza Vaccine; LAIV; Live Attenuated Influenza Vaccine; NIS-Flu; National Immunization Survey-Flu; NIS; National Immunization Survey; NIS-Teen; National Immunization Survey-Teen; CAS
Evaluation of avian influenza virus isolated from ducks as a potential live vaccine candidate against novel H7N9 viruses
Keywords: 7; AIV; avian influenza virus; LPM; live poultry market; IIV; inactivated influenza vaccine; LIV; live influenza vaccine; SPF; specific-pathogen-free; EID50; 50% egg infection dose; HI; hemagglutination inhibition; GMT; geometric mean titer; SN; serum neutra
Influence of the physiological variability of fasted gastric pH and tablet retention time on the variability of in vitro dissolution and simulated plasma profiles
Keywords: 7; BCS; biopharmaceutics classification system; Cmax; maximum plasma concentration; GI; gastrointestinal; IIV; interindividual variability; IOV; interoccasion variability; MMC; migrating motoric complex; RSD; relative standard deviation; Gastric pH variabili
Population pharmacokinetic model of fluvoxamine in rats: Utility for application in animal behavioral studies
Keywords: 7; 5-HT; 5-hydroxytryptamine; AUC; area under the curve; BW; bodyweight; CI; confidence interval; CL; systemic clearance; CV; coefficient of variation; CYP; cytochrome P450; DMSO; dimethylsulfoxide; EC50; concentration at the effect site at 50% of the maximu